

Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
José Baselga has resigned from his position as physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center less than a week after The New York Times and ProPublica reported that he had failed to disclose his conflicts of interest in scientific and medical journals and at professional meetings.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- Pam Bondi diagnosed with thyroid cancer
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
- UK Markey’s Denise Fabian: Theranostics lets us pair a diagnostic with a radioactive therapeutic that target the same molecule
- When CAM is added to standard therapies, survival rates drop, observational study finds














